Your browser doesn't support javascript.
loading
Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia.
Lyski, Zoe L; Kim, Myung S; Xthona Lee, David; Raué, Hans-Peter; Raghunathan, Vikram; Griffin, Janet; Ryan, Debbie; Brunton, Amanda E; Curlin, Marcel E; Slifka, Mark K; Messer, William B; Spurgeon, Stephen E.
Affiliation
  • Lyski ZL; Department of Molecular Microbiology and Immunology and.
  • Kim MS; Knight Cancer Institute, Oregon Health & Science University, Portland, OR.
  • Xthona Lee D; Department of Molecular Microbiology and Immunology and.
  • Raué HP; Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR.
  • Raghunathan V; Knight Cancer Institute, Oregon Health & Science University, Portland, OR.
  • Griffin J; Knight Cancer Institute, Oregon Health & Science University, Portland, OR.
  • Ryan D; Knight Cancer Institute, Oregon Health & Science University, Portland, OR.
  • Brunton AE; Oregon Health & Science University-Portland State University School of Public Health, Portland, OR; and.
  • Curlin ME; Division of Infectious Diseases, Department of Medicine, Oregon Health & Science University, Portland, OR.
  • Slifka MK; Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR.
  • Messer WB; Department of Molecular Microbiology and Immunology and.
  • Spurgeon SE; Oregon Health & Science University-Portland State University School of Public Health, Portland, OR; and.
Blood Adv ; 6(4): 1207-1211, 2022 02 22.
Article in En | MEDLINE | ID: mdl-34872103

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / COVID-19 Limits: Humans Language: En Journal: Blood Adv Year: 2022 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / COVID-19 Limits: Humans Language: En Journal: Blood Adv Year: 2022 Document type: Article Country of publication: